GRFS Stock: Price, Earnings History and SEC Filings
Grifols, S.A. (GRFS) last traded at $8.10, up 0.75% on the latest session and up 10.8% over the past month.
$8.10 +0.75%
1 month+10.81%
52-week high$9.90
52-week low$6.96
Volume803,383
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
GRFS earnings history
Earnings history is not available right now.
Latest SEC filings for GRFS
Insider filing activity
GRFS insiders filed 0 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
GRFS news
- European Equities Traded in the US as American Depositary Receipts Fall in Friday TradingOct 30, 2026 · finance.yahoo.com
- Grifols (BME:GRF) Stock Still Looks Cheap Based On Current EarningsOct 27, 2026 · finance.yahoo.com
- European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday TradingOct 26, 2026 · finance.yahoo.com
- Plasma Demand Supports Grifols, S.A.’s (GRFS) Path Back to Financial StrengthOct 23, 2026 · finance.yahoo.com
About Grifols, S.A.
Grifols, S.A. (GRFS) is a US-listed public company on Nasdaq. The SEC classifies its business as Pharmaceutical Preparations.